Shares of Uniphar plc (LON:UPR - Get Free Report) traded down 2% during trading on Wednesday . The company traded as low as GBX 200 ($2.61) and last traded at GBX 200 ($2.61). 20,595 shares traded hands during mid-day trading, a decline of 43% from the average session volume of 36,139 shares. The stock had previously closed at GBX 204 ($2.66).
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 310 ($4.05) target price on shares of Uniphar in a research report on Wednesday, September 4th.
View Our Latest Report on Uniphar
Uniphar Stock Performance
The firm has a market capitalization of £556.96 million, a P/E ratio of 1,428.57 and a beta of 0.75. The stock has a 50-day simple moving average of GBX 221.85 and a two-hundred day simple moving average of GBX 219.18. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.43.
Uniphar Cuts Dividend
The company also recently disclosed a dividend, which was paid on Friday, October 4th. Investors of record on Thursday, September 12th were issued a €0.01 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, September 12th. This represents a dividend yield of 0.25%. Uniphar's payout ratio is currently 1,428.57%.
About Uniphar
(
Get Free Report)
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.
Further Reading
Before you consider Uniphar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.
While Uniphar currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
